Ï㽶ÊÓƵ

New research led by McGill’s Goodman Cancer Research Centre improves our understanding of microÏ㽶ÊÓƵs

Ìý

Classified as: cancer research, Goodman Cancer Research Centre, MicroÏ㽶ÊÓƵ
Published on: 27 Jun 2019

Discovery could provide clues to potential therapies

Rearing its head in infancy, Christianson Syndrome is a rare disorder whose symptoms include intellectual disability, seizures and difficulty standing or walking. Although it is becoming increasingly diagnosed, with little being known about the neural mechanism behind the disease, therapeutic options for patients remain limited.

Classified as: Brain@McGill, neuroscience
Published on: 27 Jun 2019

Dr Natalie Dayan was named Quebec’s first Research Chair in Women’s Heart Health on 18 June 2019!

Category:
Published on: 19 Jun 2019

We are pleased to announce the appointment ofÌýDr. Isabelle MalhaméÌýto the Division of General Internal Medicine as of June 1, 2019. DrÌýMalhamé has been appointed to the Attending Staff of the MUHC Department of Medicine, Division of General Internal Medicine, and as an Assistant Professor in the Ï㽶ÊÓƵ Department of Medicine.Ìý

Category:
Published on: 19 Jun 2019

Cortical stimulation-induced seizures have the potential to guide epilepsy surgery, significantly reducing hospital stays

Surgery is the only way to stop seizures in 30 per cent of patients with focal drug-resistant epilepsy. A new study finds that inducing seizures before surgery may be a convenient and cost-effective way to determine the brain region where seizures are coming from.

Classified as: epilepsy, Birgit Frauscher, Francois Dubeau, Jean Gotman, Jeffrey Hall, Cortical stimulation
Published on: 11 Jun 2019

The Organization for Human Brain Mapping, the largest international scientific society for neuroimaging-based brain research,Ìýhas honoured Prof. Alan C. Evans with its Glass Brain Award

The award, presented to Evans at the 2019 Ìýcongress in Rome, recognizes lifetime achievement in the use of brain mapping to make significant discoveries about the human brain.

Classified as: MNI, Alan Evans, HBHL, neuroscience, neuroinformatics, neuroimaging
Published on: 9 Jun 2019

The Québec Cancer Consortium for Novel Therapeutics and Biomarkers (QCC), a collaboration between six leading hospital and cancer research centre sites based in Montreal led by Ï㽶ÊÓƵ’s Goodman Cancer Research Centre (GCRC) was awarded $10M in new funding from the Ministère de l’Économie et de l’Innovation (MEI) du Québec through its Fonds d’accélération des collaborations en santé (FACS) program.

Classified as: Goodman Cancer Research Centre
Published on: 4 Jun 2019

Researchers find clue to rare genetic disorder

Leber hereditary optic neuropathy (LHON) is an inherited form of vision loss that causes people to have trouble with their colour vision and difficulty seeing in the centre of their visual field. Due to the founder effect from the filles du roi, there is a disproportionate preponderance of a particular LHON mutation among the French-Canadian population.

Classified as: ophthalmology
Published on: 22 May 2019

Study could lead to development of personalized biomarkers and treatment

Individuals with autism spectrum disorder (ASD) are often lumped into a single catch-all group, despite significant differences in symptom profile and severity. Further muddying the waters when trying to understand and treat ASD, many previous studies show significant variability in findings.

Classified as: McGill Department of Psychiatry
Published on: 8 May 2019

Ï㽶ÊÓƵ’s Faculty of Medicine unveiled a new strategic research plan (SRP) for the Faculty in 2014, which was subsequently updated in 2017 as part of the strategic planning exercise known asÌýProject Renaissance.ÌýDr. Shari Baum, who recently assumed the role of Vice-Dean, Life Sciences, played an important role in the development of the most recent version of the plan. Dr.

Classified as: Project Renaissance, Strategic Research Plan
Published on: 26 Apr 2019

The telomerase holoenzyme responsible for maintaining telomeres in vertebrates requires many components in vivo, including dyskerin. Dyskerin binds and regulates the accumulation of the human telomerase Ï㽶ÊÓƵ, hTR, as well as other non-coding Ï㽶ÊÓƵs that share the conserved H/ACA box motif. The precise mechanism by which dyskerin controls hTR levels is unknown, but is evidenced by defective hTR accumulation caused by substitutions in dyskerin, that are observed in the X-linked telomere biology disorder dyskeratosis congenita (X-DC).

Published on: 23 Apr 2019

Adrien Peyrache and Stuart Trenholm will study epilepsy and vision

Two researchers from The Neuro are among just ten nationwide to receive Early-Career Capacity Building Grants this year from the Azrieli Foundation in partnership with the Brain Canada Foundation. Researchers Adrien Peyrache and Stuart Trenholm will study epilepsy and vision, respectively. The grants support early-career investigators who are conducting transformative research to advance understanding of the brain, in illness or health.

Classified as: Adrien Peyrache, stuart trenholm, epilepsy, Brain Canada, Azrieli Foundation, vision
Published on: 11 Mar 2019

Large international study will help select and categorize patients for better clinical trials

A large multi-centre study of more than 1,200 patients provides important predictors of Parkinson’s disease progression, which will allow better candidate selection for clinical trials and more effective therapy development.

Classified as: Parkinson's disease, Parkinson's, Ron Postuma, REM sleep disorder, Research
Published on: 4 Mar 2019

Scientists prove difference between expected/actual outcomes cause reward response

If you love it when a musician strikes that unexpected but perfect chord, you are not alone. New research shows the musically unexpected activates the reward centre of our brains, and makes us learn about the music as we listen.

Classified as: music, MNI, Reward System, MRI, Ben Gold, Robert Zatorre, nucleus accumbens
Published on: 12 Feb 2019

Pages

Back to top